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Background: Although good progress has been achieved in expanding immunization of children in China,
disparities exist across different provinces. Information gaps both from the service supply and demand sides hinder
timely vaccination of children in rural areas. The rapid development of mobile health technology (mHealth) provides
unprecedented opportunities for improving health services and reaching underserved populations. However, there is
a lack of literature that rigorously evaluates the impact of mHealth interventions on immunization coverage as well
as the usability and feasibility of smart phone applications (apps). This study aims to assess the effectiveness of a
smart phone-based app (Expanded Program on Immunization app, or EPI app) on improving the coverage of
children’s immunization.
Methods/Design: This cluster randomized trial will take place in Xuanhan County, Sichuan Province, China.
Functionalities of the app include the following: to make appointments automatically, record and update
children’s immunization information, generate a list of children who missed their vaccination appointments, and
send health education information to village doctors. After pairing, 36 villages will be randomly allocated to the
intervention arm (n = 18) and control arm (n = 18). The village doctors in the intervention arm will use the app
while the village doctors in the control arm will record and manage immunization in the usual way in their
catchment areas. A household survey will be used at baseline and at endline (8 months of implementation). The
primary outcome is full-dose coverage and the secondary outcome is immunization coverage of the five vaccines
that are included in the national Expanded Program on Immunization program as well as Hib vaccine, Rotavirus
vaccine and Pneumococcal conjugate vaccine. Multidimensional evaluation of the app will also be conducted to
assess usability and feasibility.
Discussion: This study is the first to evaluate the effectiveness of a smart phone app for child immunization in rural
China. This study will contribute to the knowledge about the usability and feasibility of a smart phone app for managing
immunization in rural China and to similar populations in different settings.
Trial registration: Chinese Clinical Trials Registry (ChiCTR): ChiCTR-TRC-13003960
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Substantial gains in child survival over the past two de-
cades have been achieved, but still key work is required
within the context of the Millennium Development
Goals (MDGs) on child survival [1]. Full-dose coverage
of immunization is one of the essential child health
strategies and a critical public health objective, which
was included in the World Health Organization (WHO)/
The United Nations Children’s Fund (UNICEF) Regional
Child Survival Strategy as one of the major components
of the child survival intervention package [2]. It is recog-
nized that timely vaccination, particularly within the first
six months of life, is extremely important in reducing
the burden of disease preventable by vaccines [3]. WHO
stated in 2013 that the estimated number of all deaths of
children aged less than 5 years from vaccine-preventable
diseases was 1.49 million [4].
In China, good progress has been made in introducing
Bacillus Chalmette Guerin (BCG), Oral Poliomyelitis
Vaccine (OPV), Diphtheria Pertussis Tetanus Combined
Vaccine (DTP) and Measles Vaccine since the mid-
1970s. In 1992, Hepatitis B Vaccine (HBV) was included
into the national immunization program. According to
the guideline issued by Ministry of Health in China,
caregivers of children should go to the local eligible hos-
pitals to register for an immunization card within one
month after children’s birth. In rural areas, caregivers
usually go to township hospitals or village clinics for
immunization services. The township doctors record
the name, birth date and other basic information of the
children on their immunization cards and inject the
age-appropriate vaccines according to the guideline
(Additional file 1: Table S1). After that, doctors record
the date for the next vaccines and make appointments
with caregivers.
The implementation of Expanded Program on Immu-
nization (EPI) has improved the national immunization
coverage significantly. According to the fourth National
Health Service Survey (NHSS) in 2008, around 80% of
Chinese children aged 12–59 months were fully immu-
nized (one dose of BCG and measles, three doses of
DPT, HBV and OPV) [5]. However, it varied greatly among
provinces, with the highest in Zhejiang (89.9%), the lowest
in Chongqing (46.4%), and a rate in between these two
provinces in Sichuan (70.0%). Compared to the national
target set for the year 2020 (more than 95% of children
fully immunized) [6], there is a big gap that needs to be
closed, especially for areas that have the lowest coverage. A
study in Sichuan Province aiming to evaluate the current
status of the childhood immunization concluded that the
proportion of missed and unqualified vaccination was
higher in remote rural areas [7].
An information gap both from the service supply and
demand side hinders timely vaccination of children. Astudy focusing on the low coverage of full dose im-
munization found the following reasons for failure of
vaccinating children on time: 1) village doctors reported
that the time interval between the two injections was too
long for them to remember the exact date for next injec-
tion, which resulted in the missed or overdue vaccinations.
2) caregivers reported that they did not know where to get
vaccination or which doctor was responsible for their chil-
dren’s vaccination and that they did not inform them of
the date for next immunization [8].
Mobile health (mHealth) may have great potential to
address some of the issues and challenges related to
the disparity of immunization coverage in rural China.
mHealth lacks a unified definition, but can be described
as supporting the practice of medicine and public health
by mobile devices [9]. Though the mHealth field is still
in its infancy, it can have considerable impact health
outcomes by, among other methods,extending the reach
of health information and services to remote populations
and promoting health services [9].
Recently, smart phones have found their ways into our
lives. They combine the functions of a mobile phone and
PDA (Portable Digital Assistant), in addition to enabling
Internet access and imaging and video functionality.
Apps as an indispensable part of mHealth have obtained
more and more attention. Carter et al. showed that an
app was acceptable and feasible as an intervention for
weight loss [10]. Whittaker et al. found a multimedia mo-
bile phone smoking cessation program (app) was technic-
ally feasible to help the target population to quit smoking
[11]. Both of these studies showed that the apps were ac-
ceptable and feasible as health interventions. However,
there is a lack of literature that rigorously evaluates the
impact of mHealth interventions [9,12] on childhood
immunization coverage [13,14].
To improve the current status of immunization coverage
in rural Sichuan Province, EPI app, a smart phone app, has
been developed by Save the Children and will be imple-
mented in two townships of Xuanhan County, Sichuan
Province. The aims of this study are to evaluate the usabil-
ity and feasibility of the app and to explore the effective-
ness of a smart phone app on improving immunization of
children in rural Sichuan Province, China.
Methods/Design
Design
This cluster randomized controlled trial (C-RCT) will
evaluate the effectiveness of a smart phone app, the EPI
app, on increasing immunization coverage of children
in rural Sichuan Province (Figure 1). The village doctors
will use the app to document and manage the vaccin-
ation injection records. In some villages, more than one
village doctor is eligible for child vaccination and poten-
tial contamination will be introduced if we randomize at
Figure 1 Flowchart of study.
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intervention group shares the app with another village
doctor in the control group in one village). Therefore, a
cluster design will be used and the unit of randomisation
and analysis will be the village. The effectiveness of im-
munization coverage will be collected from a Maternal,
Newborn and Child Health Household survey and assessed
by comparing outcomes between baseline and endline
(8 months after baseline).
The EPI app was developed by Save the Children and
managed jointly by Save the Children and Xuanhan
Centers of Disease Control and Prevention (CDC). Capital
Institute of Pediatrics will be involved in the monitoring
and evaluation process. Villages will be randomly allocated
to one of two groups: the intervention group where the
village doctors use a smart phone with EPI app to record
and manage the vaccination and the control group where
the village doctors use usual way to record and manage the
vaccination (Figure 2).
Study area
This trial will be conducted in Nanba and Xiaba Township,
Xuanhan County in Dazhou City, Sichuan Province, China.
Sichuan Province is located in the west part of China with
an area of 486,000 km2 and has 21 cities and 183 counties.
By the end of 2012, the total population in Sichuan
Province was 80,762,000. In 2012, the annual per capita
net income of rural residents was 7,001 Yuan [15].
Xuanhan County covers an area of 4,271 km2 and has a
total population of 1,170,000. It has 55 townships and 497
villages [16]. Nanba Township has 31 villages with a total
population of 100,000 and under 2 population of 1,350;Xiaba Township has 15 villages with a total population of
33,750 and under 2 population of 560.
Intervention
Development of the EPI app
The Android-based EPI app was developed specifically
for Xuanhan County, Sichuan Province, China by an in-
formation technology company (Cybermax, 金卫信). A
smart phone app was chosen over other information
communication technology solutions for the following
reasons: 3G wireless networks have better coverage than
broadband networks, the cost of smart phone is lower
than a computer or laptop and it is easier to carry a
smart phone when village doctors conduct out-reach
services. The development process started with a needs
assessment of village doctors in December 2012. After
reaching consensus with Save the Children, a study
supervision team consisting of different stakeholders in-
cluding project partner PATH, local health authorities,
CDCs, township hospital health workers and village doc-
tors, and the app developer, a requirement specification
of the EPI app was made early 2013. The first version of
EPI app came out in September 2013 and further pilot
testing and revising the app was conducted between
September 2013 and March 2014.
Training village doctors to use EPI app and subsequent
support
In January 2014, intervention village doctor each took
part in a one-day training workshop on the use of EPI
app. The trainers, who are the developers of the EPI
app, used a variety of techniques, including interactive
Figure 2 Management of immunization of children at township and village level.
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as competent, each village doctor had to complete a skills
assessment test satisfactorily.
Refresher workshops have been planned twice after-
wards throughout the study. Village doctors are com-
pensated for their travel costs and food while attending
the workshops. None of the participants receive salary
support or other incentives for their participation in the
study. After the initial training, each village doctor in the
intervention arm is provided with a 3G wireless network
smart phone with the pre-installed EPI app. All the fees
including phone calls, text messaging and internet access
will be paid by the program. If village doctors encounter
any problems when using the app during the study, they
can call the township doctors for help, or if not solved
by township doctors, technical support from the devel-
oper team will be provided. Moreover, a technician from
the app development company will stay in our study
area after the initial training to provide immediate tech-
nical support.
Description of the smart phone app
1) Making appointments: the app will automatically
push immunization information to each village
doctor in the intervention arm. Once a child has
established his/her immunization card, township
doctors will enter the child’s general informationand immunization information into the child EPI
information system (computer platform). The
system will automatically assign this information to
corresponding village doctors and push child’s
immunization information and scheduled vaccine
dates to village doctors’ smart phone through this
app (Figure 3).
2) Record: on the scheduled vaccine date, when a child
comes to the village clinic and gets his/her vaccine,
the village doctor will use the app to record a child’s
immunization status (name of the vaccine, date,
batch number, manufacturer, vaccine site and
whether it is a free shot or not). The updated
immunization information of a child will be updated
to the local immunization management system
automatically through the 3G wireless network.
3) Tracking: a list with the names of all children who
missed their immunization appointment three times
will be sent to village doctors in their catchment
area. The name list also includes contact
information (family phone number, cell phone
number and address) of children’s caregivers. The
village doctor will use this list to call children’s
caregivers or drop by children’s homes to remind
them about immunization.
4) Health education: program managers will tailor
health information related to immunization such as
the abnormal reactions, key knowledge and skills of
Figure 3 Screenshot of the EPI app. Legend: first screenshot shows the general function modules of EPI app. Second screenshot shows the list
of scheduled vaccination appointments. The last screenshot shows the health education information.
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this to village doctors through this app. In this way,
village doctors will learn knowledge about
immunization at any time or any place.
Co-interventions and contamination
There are no known co-occurring health programs in
this community that could potentially alter the out-
comes. In addition, no other child health trials have ever
been conducted in this community. To reduce the risk
of contamination, we will assign each village doctor in
the intervention arm a unique ID and password to log in
the EPI app to avoid smart phone share between village
doctors in the intervention arm and control arm.
Control
1) Making appointments: when caregivers take their
children to village clinics in control arm to receive
vaccines, village doctors will schedule the next
appointment for vaccination with caregivers. After
that, when they manually update children’s
information on the child EPI information system,
the system will also generate a list on paper including
the dates when children should have subsequent
vaccinations. Then village doctors will bring this list
as a reference for further appointments.
2) Record: on the scheduled vaccine date, when a child
comes to the village clinic and gets his/her vaccine,
the village doctor will record this child’simmunization status (name of the vaccine, date,
batch number, manufacturer, vaccine site and
whether it is a free shot or not) on paper. Then they
will go to township hospitals to manually input
children’s immunization information into the child
EPI information system once a month.
3) Tracking: a name list with all overdue children who
missed their immunization appointment will be
manually generated from township hospitals
monthly and then township hospital doctors will
inform the village doctors by telephone calls.
4) Health education: village doctors will be trained at
the township hospital during monthly regular
meetings.
Randomization
The unit of randomization will be the cluster, defined
by the administrative boundary for each village. Ran-
domization will be performed after the baseline house-
hold survey. A statistician outside the research team will
be responsible for the randomization.
A short pre-randomization survey was conducted to
explore the general characteristics of village doctors
who provided immunization services in their catchment
areas, as well as their mobile phone use preferences. There
are 59 village doctors that provide immunization services
in our study area.
For villages (n = 18) that have more than one village
doctor who manages immunization, we will only include
the youngest village doctor, because we assume younger
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tentially increase the uptake and sustainability of the
intervention. Four villages will be excluded because
of the small number of children (<7 children aged 12–
23 months) in these villages. One village will be randomly
excluded because we use a paired design. In total, 36
villages (18 pairs) will be included for randomization.
Package of blockTools in R [17] will be used for match-
ing and random allocation, for multiple continuous vari-
ables were allowed. We will use the number of children
younger than 1 year managed by the village doctor in
charge of vaccination injection, age of the youngest village
doctor for immunization in village, and the population
density (population/area in each village) for pair matching.
Sample size and study population
A. Sample size calculation
Base on a survey conducted in early 2013 in
Xuanhan County, Sichuang Province, the coverage
of the five key vaccines is 41.35%. We expect that
the five-vaccination coverage in intervention group
will rise from 41.35% to 65%.With level of confidence
of 95%, power of 80%, the coefficient of variation in
outcome between clusters within matched pairs (Km)
as 0.25 [18], we estimate that 7 participants from each
cluster of 18 pairs of clusters will be sufficient to detect
the difference in two groups.
B. Intervention target will be village doctor in charge of
immunization
Inclusion criteria
a. Village doctors who are in charge of immunization
(both management and injection)
b. If there are several village doctors available, we
will choose the youngest one and with the
assistant practicing license for clinical doctors
Exclusion criteria
a. Refuse to participate
b. The estimated number of children aged one to
two years in village is less than 7. The estimated
number is calculated as the number of children
reported multiplied by 75% (the average
percentage of children staying in the village) and
90% (the expected rate of contacted primary
caregivers who agree and complete the survey).
C. The survey target will be caregivers of children aged
12–23 months. Children aged over 1 year are
supposed to complete the five vaccinations required
by national EPI program. Therefore, caregivers of
children aged 12–23 month old are our survey
target in both the baseline and endline survey.
Inclusion criteria
a. Living in Xuanhan County
b. Receiving immunization service in Xuanhan Countyc. Having a child aged 12 to 23 months; if there is
more than one child aged 12 to 23 months, only
include the youngest one
d. Being a caregiver of the selected child
Exclusion criteria
a. Refuse to participate.Outcome measurement
The primary outcome is five-vaccine immunization cover-
age and the secondary outcome is immunization coverage
for Bacillus Chalmette Guerin (BCG), Oral Poliomyelitis
Vaccine (OPV), Diphtheria Pertussis Tetanus Combined
Vaccine (DTP), Measles Vaccine (MV), Hepatitis B Vaccine
(HBV), Hib vaccine, Rotavirus vaccine and Pneumo-
coccal conjugate vaccine (PCV) vaccine (Additional file 1:
Table S2).Immunization coverage will be collected by
the immunization module (IM) of the household sur-
vey. The immunization card will be collected for every
participant, and injection record including dosage and
date will be recorded with Goodata, a smart phone app
for data collection. The demographic information such as
education level, ethnicity, gravidity, parity, type of Hukou,
source of family income will also be collected by the
household and identification module (HH and ID) in
household survey, as they are factors that may potentially
influence immunization.
Multidimensional evaluation of smart phone app (EPI)
Heuristic evaluation
A heuristic evaluation is an informal usability evaluation
technique to evaluate whether user interface elements of
a system adhere to a set of usability principles known as
heuristics [19]. The purpose of the heuristic evaluation
method is to identify any serious usability problems that
users might encounter and to recommend improve-
ments to the design before implementing the system. By
evaluating the interface in the developmental phase, de-
sign problems may be identified and corrected earlier,
thus reducing potential usability errors [20].
Three experts who have experience in developing
health information systems will be invited to conduct
the heuristic evaluation. To make sure all the experts
will receive the same guidance, materials including the
user manual of EPI app, introduction of heuristic evalu-
ation and heuristic evaluation form will be provided to
them before evaluation starts. Research staff will make
sure that the experts understand the procedure of evalu-
ation and ask the experts to start using all four function
modules of the app.
Violations are defined as problems that could poten-
tially interfere with end user’s ability to interact effect-
ively with the app [21]. After finishing with all function
modules of the app, experts will fill out the heuristic
evaluation form. During evaluation sessions, experts are
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camera to record the heuristic evaluation and take field
notes. The time for completing each task and number of
errors will also be recorded.
Usability test
Usability testing is a way of ensuring that apps are
adapted to users and their tasks [22]. Usability testing
involves measuring the performance of end users doing
typical task case scenarios [22,23]. The goal of this fun-
damental step is to obtain objective performance data to
assess an app in terms of usability goals: accuracy and
acceptability. Accuracy will be measured by logging the
time spent on completing each task and number of errors.
Acceptability is defined as the extent of uptake of this app
and will be assessed using users’ perception of ease of use
and usefulness scale (PEUU) [24], which will be translated
and adapted into Chinese context before use.
About 10–15 village doctors will be recruited for us-
ability testing. The inclusion criteria for village doctors
are: 1) in charge of immunization of children in his/her
catchment area; 2) able to use a smart phone and apps;
3) do not receive any intervention in our study. In
addition, we will exclude those who refuse to participate.
Village doctors who meet our inclusion criteria will be
invited to participate. After obtaining their informed
consent, short training will be conducted to introduce how
to use the smart phone and app as well as the basic func-
tion of app, usability testing, case scenarios and the PEUU
scale assessment. Then, village doctors will be asked to use
the app to perform case scenarios. Research staff will
observe the whole process and record the time for com-
pleting each task and number of errors. Meanwhile, during
evaluation sessions, village doctors are encouraged to
“think aloud” on problems they encountered or experi-
ences while using. After obtaining their consent, research
staff will use video cameras to record the village doctors to
perform case scenarios and take field notes. After comple-
tion of case scenarios, village doctors will fill out the PEUU
scale and be encouraged to be as specific as possible.
Feasibility evaluation
Following usability testing, a feasibility evaluation will be
conducted with village doctors in our intervention arm
to determine compliance and satisfaction with the app.
A questionnaire designed by the research team and a
qualitative interview will be used to assess the user ex-
perience and satisfaction of village doctors. Technical or
hardware problems encountered while using the app will
also be collected during feasibility evaluation and regular
monitoring and evaluation using both qualitative inter-
views and checklist form.
Village doctors in the intervention arm will be enrolled
and will be given a smart phone with pre-installed appand asked to use the app to manage immunization in
their catchment areas. Telephone assistance will be avail-
able to village doctors in case of technical problems.
Every two months, research staff will call enrolled village
doctors to assess the user experience and satisfaction
when using the app with the self-designed questionnaire
and semi-structured interview. Compliance, the reason
for non-compliance, satisfaction, technical or hardware
problem encountered while using the app and sugges-
tions on improvement will be collected during feasibility
evaluation and regular monitoring and evaluation field
visits.
Data management and analysis
The primary investigator will be in charge of the data-
base maintenance and management. Data will be stored
in a computer with passwords. The primary investigator
will be responsible for the integrity and accuracy of the
data. All participants will have a unique code. Smart
phones will be used to collect data. Data will be secured
first, then exported and uploaded to the internet into a
database. Logic verification statements will be written in
data acquisition software for the mobile phone. Statis-
tical analyses will be performed by research staff blinded
to the treatment allocation.
The principle of intention-to-treat-analysis will be used.
At village level, the five-vaccine immunization coverage or
other immunization coverage indicators will be trans-
formed first and compared with paired t test or non-
parametric test. Random-effect logistic regression will be
used to test for the effect on every outcome when con-
trolled for the covariate (socioeconomic variables such as
education level, ethnicity, gravidity, parity, type of Hukou,
source of family income) on individual level.
Exploratory statistical analysis of multidimensional
evaluation of app will be used to calculate the frequen-
cies and mean severity rating scores of heuristic viola-
tions, mean logging time, number of error for each task,
score of perceived ease of use and usefulness, the per-
centage of compliance and frequency of technical or
hardware problems. Qualitative materials of the multidi-
mensional evaluation of app will be collected through
recordings and evaluation forms. The recording will be
transcribed verbatim and compared to field notes for
any inconsistency or missing information. Content ana-
lysis will be used to analyze qualitative data.
All quantitative analysis will be performed by SAS 9.1
and qualitative analysis will be performed with MaxQDA.
P < 0.05 will be considered statistically significant.
Quality control
Quality control measures of surveys and interviews
Study supervisors will be recruited from Capital Institute
of Pediatrics, who are trained and have experience with
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trained for one day including the explanation of the
questionnaire and how to collect data using a smart
phone. Role play of a standard questionnaire case will be
performed in the training course to assess inter- and
intra-interviewer reliability for completing survey instru-
ments after the training. The logic checking programs
will be embedded into the data collection app. Quality-
control measures also require that each supervisor at-
tends interviews and will be responsible for identifying
and solving problems on each survey day.
Qualitative interviewers will also be from Capital
Institute of Pediatrics and are trained in qualitative
interviewing and have had experience with conducting
interviews in the field. All recording from qualitative
interviews will be transcribed verbatim independently
by two investigators. Comparison between two copies
of transcription will be performed to check for incon-
sistencies. A third investigator will verify the transcripts
by listening to the recording again. Then the transcripts
will be imported into analytical software MaxQDA for
analysis.
Quality control measure of intervention
The quality control of intervention will be conducted in
the middle of the implementation and consists of two
parts: qualitative monitoring and quantitative monitoring.
Compliance, the reason for non-compliance, satisfaction,
technical or hardware problems encountered while using
the app and suggestions for improvement will be collected
during the monitoring and evaluation visit.
Ethical consideration and consent
The study protocol was approved by Ethics Committee
of Capital Institute of Pediatrics (SHERLL 2013080). The
research team will first communicate with staff in local
health sector to make sure they understand the overall
goal, objectives and implementation plan and to ask for
approval of the study to take place in Xuanhan County.
Consent for participation in the study will be obtained
from caregivers who fulfill the inclusion criteria at the
outset of the study. The trained interviewers will first
read out the consent form to the participant and tell
them if there are any problems, and they can refuse or
quit if there is anything making them uncomfortable. At
the end of the form, the participants will mark their
agreement through a signature.
Discussion
This paper describes the study protocol for a cluster ran-
domized controlled trial of a smart phone app on child
immunization. Given the existing gap in children im-
munization coverage in China, our study will provide
important preliminary insights in using a smart phoneapp to improve child immunization in rural China and
our study is unique in a number of ways.
First, to our knowledge, this is the first cluster random-
ized controlled trial of a mobile phone-based intervention
using a smart phone app to support village doctors who
work at primary level to manage childhood immunization.
Given the limited evidence of effective interventions for
childhood immunization in low- and middle- income set-
tings, research in this area is in great need.
Second, our study examines the mobile health inter-
vention’s effect on coverage of essential childhood vac-
cines included into national EPI using rigorous cluster
randomized controlled trial design. Moreover, we will
also evaluate intervention itself to explore its usability
and feasibility, which will provide evidence for further
scale-up. In addition with qualitative interviews, we will
also know what app functions work and what does not
work for village doctors.
However, our study also has several limitations. First, for
villages that have multiple village doctors who are in
charge of children immunization, we can only include the
youngest one. Therefore, generalizability of the results of
this trial to other settings with older doctors may be lim-
ited. We will select the youngest village doctor, because
we think they have better technology capability and the
sustainability of this intervention may be better. Second,
the participants are not blinded. However, the outcome
measures and the statistical analyses will be performed by
research staff blinded to the treatment allocation.
This study will make a significant and unique contri-
bution to our knowledge about using mHealth technol-
ogy to improve immunization of children in rural China.
The results will provide rigorous evidence to better inform
government and health services provider on whether the
smart phone app can aid better delivery of immunization
services. This can be used to improve the currently low
immunization coverage in rural Sichuan Province and
other parts in China as well as similar population in other
low- and middle-income settings.Additional file
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